Status:
COMPLETED
Acceptability of Lactacyd Femina
Lead Sponsor:
Sanofi
Conditions:
Hygiene
Eligibility:
FEMALE
18-60 years
Phase:
PHASE4
Brief Summary
To demonstrate the safety and acceptability of the gynaecological formulation.
Eligibility Criteria
Inclusion
- Integral skin in the tested region
Exclusion
- Pregnancy or breastfeeding women
- Use of anti-inflammatory or immune-suppression drugs
- Topical medication use at the tested region
- Active cutaneous gynaecological disease which may interfere in study results
- Personal history of allergic disease at the area to be treated
- Allergic or atopic history
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
559 Patients enrolled
Trial Details
Trial ID
NCT00712868
Start Date
June 1 2008
End Date
August 1 2008
Last Update
July 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
Col. Coyoacan, Mexico